The Wall Street Journal The government hopes patient testimony — if a judge allows it — in the closely watched criminal fraud trial will support the charge that Elizabeth Holmes touted the company’s medical tests as reliable despite knowing of bad results After three back-to-back miscarriages, Brittany Gould said she turned to Theranos Inc. to know if her latest pregnancy was on track. Then, one of the company’s trademark finger-prick tests indicated she was losing another baby, Ms. Gould said. The Mesa, Ariz., medical assistant recalled dreading the moment when she would have to tell her 7-year-old daughter, who was waiting for a sibling. “Mommy is not having a baby,” Ms. Gould said she told her. Like those of other patients slated as potential witnesses in the criminal trial of Theranos founder Elizabeth Holmes , Ms. Gould’s test was wrong. Prosecutors have accused Ms. Holmes of defrauding patients and investors by falsely claiming her invention could accurately perform lab tests on just a few drops of blood. Popular stories from WSJ.com:
source: https://www.marketwatch.com/story/theranos-patients-could-be-the-wild-card-in-elizabeth-holmes-trial-11628008548
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.